Date: 2025/06/02 - 19:31
A novel treatment, an aldosterone synthase inhibitor, safely and consistently lowered blood pressure in individuals with uncontrolled or resistant hypertension, a global phase 3 trial showed.
Date: 2025/06/01 - 18:31
Following a diet higher in the omega-6 fatty acid linoleic acid may help support cardiometabolic health, and lower a person's risk for type 2 diabetes and heart disease, a new study indicates.
Date: 2025/05/31 - 00:00
New research found a link between chronic cannabis use and endothelial dysfunction, a risk factor for cardiovascular disease. This association was present in cannabis users regardless of whether they smoked or ingested the substance.
Date: 2025/05/20 - 19:31
A secondary heart attack could be prevented by replacing 30 minutes of sedentary behavior with light-intensity or moderate-to-vigorous-intensity physical activity, or even with sleep.
Date: 2025/05/18 - 16:31
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.
Date: 2025/05/17 - 01:32
“Broken heart syndrome” carries a significant risk of death and serious complications. Although the condition appears to be much more common in women, men may be significantly more likely to die from it, according to new research.
Date: 2025/05/15 - 23:32
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.
Date: 2025/05/13 - 23:32
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.